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ABSTRACT
LONGITUDINAL TRAJECTORIES AND PREDICTORS OF FUNCTIONAL
IMPAIRMENT IN MILD COGNITIVE IMPAIRMENT, ALZHEIMER’S
DISEASE, AND VASCULAR DEMENTIA
SEPTEMBER 2014
LAUREN ZERANSKI CHISHOLM, B.A., DARTMOUTH COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Rebecca Ready
Functional disability in older persons with cognitive impairment is associated with
reduced quality of life and greater mortality, health care utilization, and caregiver burden.
Episodic memory, executive function, apathy, depressive symptoms, and medical burden
have been identified as cross-sectional predictors of functional disability but have
received little longitudinal investigation in a way that explicates how changes in these
variables relates to functional disability. Functional disability also drives the distinction
between the diagnoses of Mild Cognitive Impairment (MCI) and dementia; however,
little is known about the rates of functional decline in these groups over time. This study
utilized multi-level modeling to determine the longitudinal associations between episodic
memory, executive function, apathy, depressive symptoms, and medical burden and
functional decline in older persons with MCI and two of the most prevalent types of
dementia, Alzheimer’s disease and vascular dementia. Results provide support for the
longitudinal associations between memory, executive function, and apathy symptoms and
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instrumental activities of daily living (IADL) performance. Alzheimer’s disease was
associated with a faster rate of function decline than normal aging and vascular dementia,
but a rate not significantly different than seen in MCI. Longitudinal decline in IADLs
was non-significant in both normal aging and vascular dementia.
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CHAPTER I
INTRODUCTION
Due to the aging of the Baby Boomer generation, the number of Americans aged
65 and older is projected to almost double to 72 million by 2030; the number of
Americans aged 85 and older also is projected to increase to 19 million from 5.7 million
by 2050 (Federal Interagency Forum on Aging-Related Statistics, 2010). While efforts
are underway to develop treatments to prevent cognitive impairment in this population of
older adults, prevention of premature disability and institutionalization in those who
develop cognitive impairment remains an important goal. Central to this goal is an
improved understanding of functional disablement in dementia. Functional disability is
commonly described in terms of the ability to perform activities of daily living (ADLs).
These include basic ADLS (BADLs), which are simple self-care activities such as eating,
bathing, toileting, and dressing that are associated with motor functioning and basic
visuospatial abilities (Boyle, Cohen, Paul, Moser, & Gordon, 2002; Herlitz, Hill,
Fratiglioni & Backman, 1995). They also include instrumental ADLs (IADLs), which are
more complex, adaptive activities that demand higher levels of function. IADLs include
balancing a checkbook, preparing meals, driving, and using the telephone, and are tied to
higher-order cognitive processes like organization, judgment, and sequencing of
attention.
Impairments in ADLs are associated with a multitude of adverse outcomes for
persons with dementia, including decreased autonomy and quality of life, increased
mortality and health care utilization, and greater caregiver burden (Andersen, WittrupJensen, Lolk, Andersen, & Kragh- Sorensen, 2004; Covinsky, Newcomer, Fox, Wood,
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Sands, & Dane et al., 2003; Hill, Fillit, Thomas, & Chang, 2006; Razani et al., 2007).
Functional disability also is associated with increased expense. Greater functional
dependence raises odds for institutionalization into nursing homes and other long-term
care settings, at tremendous cost to families and the public welfare sector (Hill et al.,
2006).
Much of the extant literature on functional disability in dementia has focused on
cross-sectional relationships between single predictors or classes of predictors (e.g.
neuropsychiatric or cognitive variables) and functional dependence. There is converging
evidence for the power of cognition, neuropsychiatric symptoms, and, to a lesser extent,
medical burden, in predicting functional disability in cognitively impaired older adults.
Less attention has been directed towards modeling the power of these variables in
combination and over time for predicting disability. The limited longitudinal research that
is available has examined the strength of mostly cognitive predictors at baseline in
determining later functional outcomes (Bennett et al., 2002; Royall, Palmer, Chiodo &
Polk, 2004). Information on annual rates of change in functional dependence in MCI,
Alzheimer’s disease, and vascular dementia also is limited. Only one study has used
advanced statistical methods to estimate the level and annual rate of change in the ability
to perform IADLs in persons with MCI and dementia (Tomaszewski Farias et al., 2009).
This study assessed a small sample of participants and warrants replication.
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CHAPTER II
LITERATURE REVIEW
Overview of Functional Disability in Mild
Cognitive Impairment and Dementia
Pattern of Decline
Functional disablement in persons with dementia typically occurs in a progressive
pattern whereby IADLs decline first, followed by BADLs; however, individual
variability has been seen in both the rate of decline and the order in which activities
become compromised (Arrighi, Gelinas, McLaughlin, Buchanan & Gauthier, 2013).
Performance of complex activities often begins to decline years prior to diagnosis.
Indeed, transportation and telephone use, and management of finances and medications
have been found to diverge significantly in predementia subjects from normal controls
five and six years prior to dementia diagnosis (Amieva et al., 2008). Difficulties in
driving also have been reported before detectable cognitive impairment in older adults
(Fields et al., 2010). In contrast, deterioration of BADLs typically occurs in the later
stages of dementia, when patients become dependent on others for care. After an
individual becomes dependent in BADLs, he or she may lose the capacity for speech and
posture (Desai, Grossberg, & Sheth, 2004).
Typical Levels of Impairment by Diagnosis
Little normative data exist regarding differences in the extent of functional
disability in normal cognitive aging, MCI, and dementia subtypes (Rockwood, 2007).
Historically, diagnostic criteria for MCI stipulated that persons must have essentially
normal functional abilities; however, cross-sectional research suggests that individuals
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with MCI demonstrate more functional impairments than persons with normal aging but
fewer impairments than persons with dementia (Albert, Tabert, Dienstag, Pelton, &
Devanand, 2002; Aretouli & Brandt, 2010; Brown, Devanand, Liu, & Caccappolo, 2011;
Farias et al., 2006; Pereira, Yassuda, Oliviera, & Forlenza, 2008; Wadley, Okonkwo,
Crowe, & Ross-Meadows, 2008; Yeh et al., 2011). Based on this research, recent
revisions to the MCI diagnostic criteria allow for mild difficulty in IADLs as well as
some assistance in performing these activities (Morris, 2012). However, the field
continues to lack consensus on how much functional dependence should be exhibited,
and in what domains, before a diagnosis of dementia is warranted (Farias et al., 2006;
Gold, 2012).
Data regarding differences in functional limitations by dementia subtype also is
limited and conflicting. Cross-sectional research has described greater limitations in
BADLs in persons with vascular dementia compared to those with Alzheimer’s disease,
controlling for medical comorbidities and dementia severity, but no significant
differences in IADLs (Gure, Kabeto, Plassman, Piette & Langa, 2010). A review of the
literature on functional impairment in vascular dementia describes functional decline of a
similar nature, but with a slower trajectory in vascular dementia, than that seen in
Alzheimer’s disease (Boyle & Cahn-Weiner, 2004), a conclusion replicated recently by
Gill et al. (2004). More longitudinal research is needed to better understand the course of
functional decline in vascular dementia and how it compares to changes seen in normal
aging, MCI, and Alzheimer’s disease, controlling for other predictors of disability.
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Cognitive Impairments and Functional Disability
Overall Association Between Cognitive and Functional Impairments
Functional disability may result from impairments in memory, language,
visuospatial abilities, planning, organization, and divided attention (Farias et al., 2006).
Based on a comprehensive review of the literature of the relationship between cognition
and functional status in older persons with cognitive impairment, Royall and colleagues
(2007) found that cognitive variables account for a modest proportion (20%) of variance
in functional outcomes. Global cognitive ability has consistently predicted functional
outcomes in both cross-sectional and longitudinal research (Bennett et al., 2006; Royall et
al., 2004). Tests of general cognition including the Mini Mental State Exam, the
Dementia Rating Scale, the Mattis Dementia Rating Scale, and the Short Portable Mental
Status Quotient are associated with functional status in dementia patients (Baird, Podell,
Lovell, & McGinty, 2001; Royall et al., 2007; Tekin, Fairbanks, O’Connor, Rosenberg,
& Cummings, 2001). This evidence is not surprising given that greater functional
dependence typically accompanies greater disease severity. Associations between
specific cognitive domains and functional disability have been studied and show that
memory and executive functions consistently predict everyday functioning in cognitively
impaired older adults.
Memory
Memory impairment is the hallmark symptom of dementia and of amnestic MCI,
the most prevalent subtype of MCI that is chiefly characterized by memory decline.
Episodic memory is memory for information that is personally experienced and is more
impaired than memory for general information (i.e., semantic memory) in amnestic MCI
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and AD (Albert et al., 2011; Sperling et al., 2010). Several studies demonstrated crosssectional relationships between episodic memory and functional abilities. For example, in
assisted living residents, a 10-point decline on a word-list verbal learning task predicted a
6-point decline on a functional impairment measure (Burdick et al., 2002). Another study
of admissions to a geriatric inpatient unit determined that immediate recall performance
on a verbal memory test (Logical Memory I, WMS-R; Wechsler, 1987) was significantly
correlated with scores on a performance-based measure of ADLs, particularly in the
domains of safety (r = 0.30), money management (r = 0.30), and medication management
(r = 0.44; Richardson, Nadler, & Malloy, 1995). Verbal memory also has been shown to
predict 23% of the variance in an informant-rated measure of everyday functioning in a
large multicultural sample of community-dwelling older adults (Farias, Mungas, Reed,
Haan, & Jagust, 2004).
Executive Function
Executive abilities also are a consistent predictor of functional disability.
Executive function broadly relates to the regulation of multiple cognitive processes
including the planning, coordination, and execution of a response, mental flexibility,
response inhibition and self-monitoring. Due to its conceptualization as the brain’s
central executive, impaired executive function can result in poor coordination of multiple
cognitive functions (Cahn-Weiner et al., 2007) and thus impair performance on memory
or attention tasks. Conversely, intact executive abilities may mediate the effect of
impairment in other specific cognitive domains, such as memory, on functional status
(Cahn-Weiner et al., 2007). For instance, the ability to coordinate mental functions,
sequence attention, and plan and organize behaviors may allow an individual to
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successfully utilize compensatory strategies, such as notes or to-do lists, and thereby
reduce the effects of memory impairment on ADLs.
A review of cognitive predictors of functional status determined that tests of
executive cognition predict an average of 6.5% of the variance in functional outcome
measures (Royall et al., 2007). Problems with executive function have been significantly
associated with IADL limitations in community-dwelling older adults with subclinical
levels of cognitive impairment (Royall, Chiodo, & Polk, 2000), and baseline executive
abilities, as measured by a composite scale, have predicted later change in everyday
function in persons with a range of cognitive functioning, from normal cognitive aging to
moderate dementia (Cahn-Weiner et al., 2007).
Working memory may be particularly useful in predicting functional disability
(Aretouli & Brandt, 2009). Part B of the Trail-Making Test (TMT-B), a commonly used
test of working memory and set shifting, has predicted everyday functioning in research
with older adults with a range of cognitive impairment. Scores on the TMT-B accounted
for 25% of the variance in BADLs and IADLs in a study of assisted living residents
(Burdick et al., 2005). A similar relationship was found between TMT-B scores and
performance on IADL items from the Disability Assessment in Dementia in persons with
amnestic MCI (r = 0.23) and specifically with the planning, organization, and
performance aspects of these tasks (Yeh et al., 2011). TMT-B scores were highly
correlated with scores on the Independent Living Scales, an objective measure of ability
to perform IADLs, in a study of community-dwelling elderly with and without dementia
(r = -0.71; Bell-McGinty, Podell, Franzen, Baird, & Williams, 2002).
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Relative Associations of Memory and Executive
Function with Functional Disability
Given the consistent associations between episodic memory and executive
function and functional disability, recent research has attempted to determine their
relative strengths in predicting everyday functioning in persons with cognitive
impairment. In a longitudinal study of 106 older adults followed for an average of five
and a half years, both memory and executive function were associated with baseline and
longitudinal IADLs, such that poorer performance in both domains correlated with more
impaired functional status as well as a faster rate of functional decline (Cahn-Weiner et
al., 2007). However, when both memory and executive function were included in a model
of longitudinal functional change, the relationship between memory and functional
decline became non-significant and only executive function predicted functional decline
over time (Cahn-Weiner et al., 2007). Likewise, a meta-analysis of studies about
cognition and functional outcomes in older adults with cognitive impairment determined
that executive function has a stronger association with functional disability than memory,
and that the association between memory and functional status is attenuated by executive
function and age, such that its independent contribution is basically non-significant
(Royall et al., 2007).
Two studies that examined the longitudinal relationships between change in
memory and executive function and change in functional abilities provide conflicting
results. In one study, change in executive function but not memory was independently
associated with IADL performance (Royall, Palmer, Chiodo, & Polk, 2005). In the other,
changes in episodic memory and executive functions provided independent and additive
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contributions to changes in IADLs (Tomaszewki Farias et al., 2009). Thus, it is presently
unclear whether executive function is a stronger predictor of functional disability or
whether, controlling for executive function, memory also plays a unique role.
Neuropsychiatric Symptoms and Functional Disability
Prevalence of Neuropsychiatric Symptoms in
Mild Cognitive Impairment and Dementia
As stated earlier, performance on cognitive testing predicts only a modest
proportion of the variance in ADLs in persons with cognitive impairment, indicating that
other variables also predict function (Fischer, Verhoeff, Churchill, & Schweizer, 2009;
Royall et al., 2007). Empirical support has been provided for the contribution of
neuropsychiatric, or behavioral, symptoms to functional limitations in MCI and dementia.
Neuropsychiatric symptoms, as measured by the total score on the Neuropsychiatric
Inventory (NPI), account for 30% of the variance in IADLs, suggesting that they may be
as powerful as cognition in predicting functional status in dementia (Tekin et al., 2001).
Neuropsychiatric symptoms are prevalent in dementia and increase with disease
severity (Okura et al., 2010). They appear to be equally prevalent among persons with
Alzheimer’s disease and vascular dementia (Echávarri et al., 2013). A longitudinal study
of persons with dementia reported five -year prevalence rates of 77% for depression, 71%
for apathy, and 62% for anxiety, with greatest symptom severity in the apathy domain
(Steinberg et al., 2008). Neuropsychiatric symptoms also are common in MCI but
estimates of prevalence are widely variable. One longitudinal study documented a
prevalence rate of 43% in persons with MCI, with symptoms reaching the level of
clinical significance in approximately 29% of cases (Lyketsos et al., 2002). Another
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longitudinal study found that as many as 75% of participants with MCI exhibited at least
one neuropsychiatric symptom, and 37% endorsed four or more symptoms, with anxiety
(39%) and depression (35%) the most common (Edwards, Spira, Barnes, & Yaffe, 2009).
While some neuropsychiatric symptoms may be transient, several symptoms, including
delusions, depression, apathy, and aberrant motor behavior are likely to persist across
time (Steinberg et al., 2008).
Associations with Functional Disability
As compared to those with minimal symptoms, persons with MCI who have four
or more neuropsychiatric symptoms evidence greater functional limitations and twice the
risk for incipient dementia (Edwards et al., 2009). Similarly, the emergence of behavioral
symptoms in individuals with Alzheimer’s disease has been associated with increasing
functional limitations (Trachtenberg, Weiner, Patterson, Gamst, & Thal, 2002). The
presence of three or more neuropsychiatric symptoms, and one clinically significant
symptom, is associated with higher odds of functional disability in dementia patients
(Okura et al., 2010). While several studies have analyzed the contribution of noncognitive symptoms as a whole or as symptom clusters to functional outcomes, there is
less research on the independent contributions of specific symptoms. An understanding of
which neuropsychiatric symptoms are most strongly associated with functional disability
may encourage health care providers and loved ones to vigilantly monitor for their
presence and aggressively treat these symptoms to reduce their potentially modifiable
effects on function. As reviewed below, among neuropsychiatric symptoms, apathy and
depression are the most consistent cross-sectional predictors of functional disability in
older adults with cognitive impairment.
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Depressive Symptoms
Depressive symptoms are common in MCI and depressive symptoms are
experienced by approximately 75% of persons with dementia (Edwards et al., 2009;
Steffens & Potter, 2008). The nature of the relationship between depressive symptoms
and functional disability remains unclear. It has been suggested that depressive symptoms
are associated with increased disability due to distress resulting from awareness of one’s
functional limitations or due to its associations with reduced motivation (Fitz & Teri,
1994). Alternatively, late life depression and dementia may be driven by the same
underlying pathology. The pervasiveness of depressive symptoms in persons with
cognitive impairment has led researchers to hypothesize that depression may be a risk
factor for dementia, a prodromal stage before impairment, or a part of the same
pathophysiological process (Barnes et al. 2012; Lyketsos, 2010).
Depression has independent effects on cognition, such that depressed older adults
perform consistently worse than non-depressed peers on neuropsychological tests, most
notably measures of processing speed, acquisition and retrieval of new information, and
executive functions (Steffens & Potter, 2008). In this way, depressive symptoms can
exacerbate existing functional impairments in persons with cognitive impairment
(Hinton, Farias, & Wegelin, 2008). Depressive symptomatology also can provide unique
contributions to functional disability in dementia. In a sample of persons with
Alzheimer’s disease, with and without depression, the presence and severity of depressive
symptoms predicted IADL performance, controlling for cognitive function. Not
surprisingly, daily functioning was most compromised in participants with severe
depression (Fitz & Teri, 1994). Similarly, a population-based study of older Italians with
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very early dementia revealed that depressive symptoms tripled the risk for disability in
IADLs compared to the diagnosis of early dementia alone (DeRonchi et al., 2005).
Apathy
Like depression, apathy is associated with functional disability. Apathy is
characterized by loss of interest, social withdrawal, and generally decreased motivation,
initiation, and persistence in the absence of low mood or depressive thought patterns
(Fones, 1998; Ishii, Weintraub, & Mervis, 2009). In persons with cognitive impairment,
apathy may be more common than depression, which is characterized by guilt, sad mood,
hopelessness and poor self-concept (Landes, Sperry, & Strauss, 2005). Estimated
prevalence rates for apathy in persons with MCI range from 3-60% (Ellison, Harper,
Berlow, & Zeranski, 2008). It has been estimated to affect 55% of persons with AD and
70% of persons with mixed AD/vascular dementia in clinical practice (Mulin et al.,
2011). Informant-rated apathy symptoms have been significantly associated with
impairment in both BADLs and IADLs in dementia clinic outpatients (Clarke et al.,
2008). In a study of persons with vascular dementia, apathy symptoms accounted for
36% of the variance in total ADL impairment (both BADLs and IADLs), controlling for
dementia severity (Zawacki et al., 2002).
Due to the recognition that depression and apathy are not the same construct,
there is a need to distinguish their independent contributions to daily functioning. Thus
far, only a few cross-sectional studies addressed this question. In persons with probable
or possible Alzheimer’s disease, apathy was found to be more common (59.5 %) than
dysphoria (8.4%) and more strongly related to functional disability (r = 0.57) than
dysphoria (r = 0.21) (Landes et al., 2005). Another study of 195 community-dwelling
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Chinese elderly with questionable dementia (comprising MCI and very mild dementia)
and 95 persons with Alzheimer’s disease found that apathy and depressive symptoms
were differentially associated with functional abilities in the two groups. Apathy,
depression, or the combination predicted poorer functional performance in participants
with questionable dementia. Among participants with Alzheimer’s disease, apathy alone
predicted poorer functional performance. Specifically, in persons with Alzheimer’s
disease, apathy was associated with impairments in planning, initiating and executing
IADLs, while depression only was associated with impaired initiation and planning
(Lam, Tam, Chiu, & Lui, 2006). Similarly, apathy and not depression has been associated
with greater functional disability in persons with amnestic MCI (Zahodne & Tremont,
2013). Additional research is needed to replicate these findings and determine whether
depression and apathy independently predict functional loss.
Medical Burden and Functional Disability
Poor physical health is another established predictor of functional limitations in
aging. Longitudinal investigations have found that cardiovascular risk factors, including
hypertension, Type II diabetes, and obesity are associated with greater functional
limitations in late life (Newman et al., 2009). Lower levels of disease burden are
associated with recovery from functional limitations (Knoefel & Patrick, 2003; Miller et
al., 2004). These conclusions largely have been reached through community-based
studies, and information regarding the relationship between medical disease burden and
functional abilities in persons with cognitive impairment is limited. One cross-sectional
study of 143 clinic outpatients with probable or possible Alzheimer’s disease found no
relationship between overall medical burden and IADL impairment (Tekin et al., 2001)
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while another study using a larger sample (n= 999) of clinic outpatients and residents of
assisted living facilities and nursing homes found significant associations between scores
on a general rating of medical comorbidity and functional impairment (Lyketsos et al.,
1999). In another study of 198 residents of assisted living facilities, the difference
between excellent and fair health ratings had a comparable association with increased
functional disability as a 7-point, or 23% drop in score on the Mini Mental State Exam, a
commonly-used brief assessment of global cognitive impairment (Burdick et al., 2005).
Clearly, more research is needed to clarify these discrepant findings and determine the
relationship between medical illness burden and functional disability in persons with
cognitive impairment. In addition, the relative strength of the relationship between
medical burden compared to cognitive and neuropsychiatric predictors of disability
remains an important question.
The Current Study
The proposed study expands our understanding of predictors of functional
disability by examining longitudinal associations between cognitive, neuropsychiatric,
and medical factors and functional disability in a large outpatient sample of persons aged
60+ with MCI, Alzheimer’s disease, and vascular dementia from the Massachusetts
Alzheimer’s Disease Research Center’s Longitudinal Study on Memory and Aging.
Specifically, the current study determined the longitudinal relationships between episodic
memory, executive function, apathy, depression, and medical burden and IADLs. In
addition, the current study provides precise estimation of average annual rates of
functional change for persons with a given baseline diagnosis (MCI, Alzheimer’s disease,
or vascular dementia) in comparison to older adult controls.
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This study adds to the literature in several ways. First, it replicates and attempts to
resolve contradictions posed by the few prior investigations of the longitudinal
relationship between cognitive impairment and functional impairment in persons with
MCI and dementia. Second, it extends these findings by considering other established
cross-sectional predictors of functional disability in persons with cognitive impairment:
the neuropsychiatric symptoms of depression and apathy, and general medical burden. In
so doing, this study adds to our understanding of what factors contribute to functional
disability in persons with cognitive impairment. Third, the current study measures the
average level of functional impairment in MCI, Alzheimer’s disease, and vascular
dementia, as well as the average annual rate of change in persons with these diagnoses.
This information can help patients, caregivers, and health care providers plan future care
needs.
Specific Aims
Aim 1
Determine the longitudinal associations between episodic memory, executive
function, depression, apathy, and medical disease burden and IADLs in a sample of
persons with baseline diagnoses of Mild Cognitive Impairment, mild to moderate
Alzheimer’s disease, and vascular dementia.
Hypotheses
Episodic memory and executive function will predict everyday function such that
greater impairments in memory and executive function will be associated with greater
dependence in IADLs (Royall et al., 2005; Tomaszewski Farias, 2009). In addition to
memory and executive function, longitudinal changes in depression, apathy, and medical
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burden will be associated with longitudinal changes in function (Burdick et al., 2005;
Clarke et al., 2008; De Ronchi et al., 2005; Fitz & Teri, 1994; Lyketsos et al., 1999;
Zawacki et al., 2002). Increased depression, apathy, and medical burden will predict
greater dependence in IADLs.
Aim 2
Determine the average level of dependence in IADLs in persons diagnosed at
baseline with MCI, mild to moderate Alzheimer’s disease and vascular dementia, as
compared to persons with normal cognitive aging.
Hypothesis
Persons with MCI will exhibit intermediate levels of IADL dependence,
compared to persons with normal cognitive aging and persons with dementia, who will
have the greatest levels of IADL dependence (Albert et al., 2002; Aretouli & Brandt,
2010; Brown, Devanand, Liu, & Caccappolo, 2011; Farias et al., 2006; Pereira, Yassuda,
Oliviera, & Forlenza, 2008; Wadley, Okonkwo, Crowe, & Ross-Meadows, 2008).
Participants with Alzheimer’s disease and vascular dementia will exhibit comparable
levels of IADL dependence (Boyle & Cahn-Weiner, 2004; Gure et al., 2010).
Aim 3
Determine how initial diagnostic status of MCI, Alzheimer’s disease, or vascular
dementia relates to average annual rate of change in the ability to independently perform
IADLs, in comparison to normal controls.
Hypotheses
Individuals with MCI will evidence slower rates of change in their ability to
independently perform IADLs than persons with dementia but steeper declines than
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persons with normal cognitive aging (Albert et al., 2002; Aretouli & Brandt, 2010;
Brown, Devanand, Liu, & Caccappolo, 2011; Farias et al., 2006; Pereira, Yassuda,
Oliviera, & Forlenza, 2008; Wadley, Okonkwo, Crowe, & Ross-Meadows, 2008).
Persons with Alzheimer’s disease will evidence steeper rates of functional decline than
persons with vascular dementia (Boyle & Cahn-Weiner, 2004; Gill et al., 2013).
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CHAPTER III
METHOD
Participants
Data from 643 participants of the Massachusetts Alzheimer’s Disease Research
Center’s (MADRC’s) "Longitudinal Cohort on Memory & Aging" project were used in
this study. Participants were recruited in several ways. Approximately 10% of the cohort
was recruited by the MADRC’s Education and Information Transfer Core, through a
variety of outreach initiatives that include advertisements in minority-targeted
newspapers and presentations at minority-focused events. Other participants were
referred from affiliated clinics of the Massachusetts General Hospital (MGH): 18% from
the MGH Memory Disorders Unit; 10% from the MGH Movement Disorders Unit; and
approximately 1% from Brigham & Women's Hospital. Nine percent are spouses or other
caregivers of patients with dementia, and approximately 18% were recruited from the
MGH Department of Psychiatry's Gerontology Research Unit. Other sources of
recruitment and enrollment include enrollees in the Nurses' Health study (approximately
4%) and individuals who participate in the MADRC's clinical trials or other studies.
Number of study visits ranged from 1-6 (M = 2.4, SD = 1.3). Approximately 35.8% had 1
visit, 25.8% had 2 visits, 20.2% had 3 visits, 12.8% had 4 visits, 4.2% had 5 visits, and
1.1% had 6 visits.
Of the total sample used for this study, at baseline, 271 persons exhibited normal
cognitive aging (42%), 153 were diagnosed with MCI (24 %), 188 were classified as
having probable or possible Alzheimer’s disease cases (29%) and 31 were diagnosed with
vascular dementia (4.8%). Mean baseline global CDR was significantly lower in persons
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with normal cognitive aging than in persons with MCI, Alzheimer’s disease, and vascular
dementia. Baseline global CDR scores in these latter groups did not significantly differ
from each other (Table 2). Those classified as normal cognitive aging at baseline were
significantly younger than persons diagnosed with MCI, Alzheimer’s disease, and
vascular dementia (Table 2). There was a significant difference in the gender distribution
of diagnostic groups: χ2 (3) = 24.47, p < 0.001. Thirty percent of persons with normal
cognitive aging at baseline were male, compared to 45% of the MCI, 48% of the
Alzheimer’s disease, and 68% of the vascular dementia groups. Participants had on
average a college education and there was no significant difference in educational
attainment between diagnostic groups. Across all diagnostic groups, participants were
predominantly Caucasian, married or partnered, and living at home with a spouse/partner
(Table 1).
Table 1
Descriptive Statistics for Participant Demographics at Baseline by Diagnostic Group

a

NCA
(n = 271)

MCI
(n = 153)

AD
(n = 188)

VaD
(n = 31)

Race
Caucasian (%)
African American (%)
Asian (%)
Hispanica (%)

240 (89)
29 (11)
2 (<1)
2 (<1)

136 (89)
11 (7)
6 (4)
2 (1)

178 (95)
9 (5)
1 (<1)
3 (2)

26 (84)
4 (13)
1 (3)
1 (3)

Living Situation
Lives alone (%)
With spouse/partner (%)
With relative/friend (%)
With group (%)
Other/unknown (%)

71 (26)
179 (66)
16 (6)
1 (<1)
4 (1.5)

44 (29)
96 (63)
9 (6)
—
4 (3)

34 (18)
139 (74)
11 (6)
—
4 (2)

8 (26)
23 (74)
—
—
—

Marital Status
Married (%)
Widowed (%)
Separated/divorced (%)
Never married (%)
Living as married (%)
Other/unknown (%)

180 (66)
35 (13)
27 (10)
20 (7)
1 (<1)
8 (3)

97 (63)
36 (24)
12 (8)
4 (3)
1 (<1)
3 (2)

139 (74)
27 (14)
10 (5)
10 (5)
2 (1)
—

23 (74)
1 (3)
4 (13)
1 (3)
—
2 (6)

Hispanic ethnicity coded in addition to race.
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Table 2
Descriptive Statistics for Model Variables at Baseline

a

CDR global
FAQa,b,c
Number medicationsa
Trail-Making Test Bb,c,d
WMS-R Logical Memory IIa
NPI-Q Depressiond
NPI-Q Apathyb,c
GDSd
Agea
Education
Gender (% male)
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a

NCA
(n = 271)

MCI
(n = 153)

AD
(n = 188)

VaD
(n = 31)

0.28 (0.42)
0.01 (0.09)
4.87 (3.45)
82.26 (64.81)
13.41 (3.38)
0.12 (0.37)
0.03 (0.17)
0.94 (1.61)
72.73 (7.00)
16.31 (2.45)
30

0.46 (0.58)
0.30 (0.43)
6.09 (4.11)
148.28 (121.30)
8.22 (4.33)
0.34 (0.65)
0.14 (0.44)
1.97 (2.03)
77.49 (6.64)
15.73 (2.95)
45

0.48 (0.54)
0.98 (0.95)
6.14 (3.27)
233.21 (264.83)
6.16 (6.14)
0.27 (0.56)
0.39 (0.69)
1.78 (1.92)
77.63 (6.92)
15.96 (3.31)
48

0.48 (0.56)
0.66 (0.84)
7.06 (4.56)
148.35 (176.84)
10.58 (5.94)
0.37 (0.62)
0.23 (0.50)
2.07 (1.60)
77.45 (8.48)
16.29 (2.94)
65

In posthoc tukey pairwise comparisons, NCA mean was significantly different from all other means (p < 0.001).
In posthoc tukey pairwise comparisons, MCI mean was significantly different from AD mean (p < 0.001).
c
In posthoc tukey pairwise comparisons, AD mean was significantly different from VaD mean (p = 0.01).
d
In posthoc tukey pairwise comparisons, NCA mean was significantly different from MCI mean (p < 0.001).
*p < .001. **p < .0001.
b

F
7.59 (3, 639)**
104.52 (3,639)**
7.63 (3, 639)*
30.95 (3,639)**
97.29 (3,639)**
7.50 (3, 639)**
23.34 (3,639)*
14.60 (3,639)**
25.08 (3,639)*
1.5 (3,639)

Measures
Functional Assessment
Functional disability was measured by the Functional Activities Questionnaire
(FAQ; Pfeffer, Kurosaki, Harrah, Chance, & Filos, 1982; Appendix A). The FAQ is a 10item questionnaire that assesses a patient’s independence in IADLs including paying
bills, preparing a balanced meal, remembering appointments, etc. Questions can be
scored from 0-3, with 0 = normal or intact abilities; 1= some difficulty but independent; 2
= requires assistance, and 3 = dependent. Higher scores indicate greater disability. The
rater also can record which activities the patient never performed. To adjust for items that
the participant never performed, the mean FAQ item score for each participant was used
in the current study to represent IADL disability, rather than the sum of scores for all
items. Thus, while total scores on the FAQ can range from 0-30, the possible range for
the outcome variable in the current study is 0-3 (the score range for an individual item).
The FAQ is clinician-rated based on informant report and has demonstrated high interrater reliability (r = 0.80 - 0.97; Pfeffer et al., 1982). The assessment has demonstrated
adequate sensitivity (0.85) and specificity (0.81) in distinguishing cognitively normal and
impaired older adults (Pfeffer et al., 1982). Previous analysis of data from the National
Alzheimer’s Coordinating Centers (NACC) found that the FAQ distinguishes between
persons with MCI and very mild Alzheimer’s disease with 80.3% sensitivity, 87%
specificity, and 84.7% accuracy (Teng, Becker, Woo, Knopman, Cummings, & Lu,
2010). Cronbach’s alpha for the 10 FAQ items in the current study sample was 0.90,
indicating excellent internal consistency.
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Episodic Memory
Episodic memory was measured by the Logical Memory II test (Story A) from the
Wechsler Memory Scale- Revised (WMS-R; Wechsler, 1987; Appendix D). The Logical
Memory II test from the WMS-R (Wechsler, 1987) measures episodic memory via
delayed recall of a short story that is read to the examinee. This test is routinely given to
all MADRC study participants at each study visit. The delayed recall score of Logical
Memory was chosen because it is considered a reliable measure of episodic memory that
is highly convergent with other verbal learning tests (Lezak, Howieson, & Loring, 2004).
Internal consistency reliability for WMS-R Logical Memory II has been estimated at r =
0.75, inter-rater reliability was estimated to be high (r = 0.97), and test-retest reliability
for persons aged 65-74 was estimated to range from r = 0.78 - 0.85 (Wechsler, 1987).
The WMS-R Logical Memory test demonstrated sensitivity in discriminating persons
with neurological deficits from those without, including persons with dementia
(Wechsler, 1987).
Executive Function
Executive function was represented by performance times on part B of the TrailMaking Test (TMT; Reitan & Wolfson, 1993; Appendix E). Part A (TMT-A) requires the
examinee to rapidly connect numbers 1-25 in order and is a test of visual scanning and
mental processing speed motor and visual processing speed. Part B (TMT-B) represents
added complexity in that it is comprised of numbers and letters and requires the examinee
to connect the numbers and letters in order from lowest number, to first letter, to the next
number and the next letter (1-A-2-B-3-C) and so on. As such, part B is a test of
sequencing, set-shifting, and mental flexibility (Arbuthnott & Frank, 2000; Reitan &

22

Wolfson, 1993). A review of the available literature suggests that the TMT has adequate
test-retest reliability and high inter-rater reliability; TMT-B has demonstrated construct
validity through convergence with several executive functions including executive
control, cognitive flexibility, and set switching (Strauss, Sherman, & Spreen, 2006).
Performance on the TMT-B has demonstrated ecological validity in predicting IADL
performance in older adults and is sensitive to neurological deficits including dementia
(Cahn-Weiner, Boyle, & Malloy, 2002; Bell- McGinty et al., 2002; Strauss, Sherman, &
Spreen, 2006).
Neuropsychiatric Symptoms
Depression and apathy were measured by the NPI-Q (Kaufer et al., 2000;
Appendix B), a brief questionnaire form of the Neuropsychiatric Inventory (NPI). The
NPI-Q has high convergent validity (r = 0.91) with the NPI (Kaufer et al., 2000). The
NPI-Q is designed to be self-administered to an informant, who is asked about the
presence over the past four weeks of each of twelve neuropsychiatric symptoms:
delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety,
euphoria/elation, apathy/indifference, disinhibition, irritability/lability, aberrant motor
behavior, nighttime disturbances, and appetite/eating changes. If the informant endorses a
symptom, he/she then rates whether the symptom is mild (1 point), moderate (2 points),
or severe (3 points). NPI-Q item score can thus range from 0-3, and total score can range
from 0-36, with higher numbers indicating greater presence of neuropsychiatric
symptoms. Test-retest reliability for the NPI-Q symptom is adequate (r =.80; Kaufer et
al., 2000). In order to examine the specific associations between depression and apathy
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and functional disability, NPI-Q total score was not used in this study. Instead, scores on
the apathy and depression items from the NPI-Q were extracted for analyses.
Self-reported depressive symptoms, as measured by the Geriatric Depression
Scale (15-item version; Sheikh & Yesavage, 1986; Appendix C) also were included to
determine whether informant-reported and self-reported depressive symptoms are
differentially associated with functional disability. The GDS-15 is a 15-item measure
intended for older adults that assesses self-reported depressive symptoms and is routinely
administered to all MADRC participants as part of the UDS. Questions assess the
presence of symptoms in the past week, and are answered in a dichotomous yes/no
format. One point is given for each depressive symptom endorsed, for a total score range
of 0-15. Analysis of the psychometric properties of the GDS-15 suggest that it has
moderate internal consistency reliability, adequate criterion validity between depressed
and non-depressed older persons, and acceptable construct validity with other indicators
of depression including depressed mood, life satisfaction and suicidal ideation (Friedman,
Heisel, & Delavan, 2005). Internal consistency and construct validity were similar for
community-dwelling elders with high and low functional dependence (Friedman, Heisel,
& Delavan, 2005). Cronbach’s alpha for the GDS-15 in this study sample was 0.73,
indicating acceptable internal consistency.
Medical Burden
Medical burden was represented by the sum of prescription medications used at
each visit. Over-the-counter medicines and vitamins/supplements were not included in
the count. Simple medication counts reliably predict health care cost and utilization,
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hospitalizations, and mortality in older adult outpatients, and compare favorably to other,
more complex assessments of medical comorbidity (Perkins et al., 2004).
Procedure
Approval from the Partners Healthcare Institutional Review Board (IRB) was
granted before analysis of de-identified patient data from the Massachusetts Alzheimer’s
Disease Research Center (MADRC).
MADRC Data Collection
A Uniform Data Set (UDS), as required by the NIH/NIA for all federally funded
Alzheimer's Disease Centers (ADCs), is collected from each participant, and data are
stored locally in the ADRC database, as well as routinely submitted electronically to the
National Alzheimer's Coordinating Center (NACC) (www.alz.washington.edu) data
repository. The UDS was first collected by all ADCs on September 1, 2005. Subjects are
seen approximately every 12 months. The initial visit must be an in-person visit, but
follow-up visits may be in-person (preferred) or via the telephone. Cognitive testing is
not administered during telephone follow-up visits. Participants are strongly encouraged
to bring an informant to the study visit. Each study visit may last from 1.5 to 2 or more
hours. During each visit, both participants and informants are assessed/interviewed by the
study doctor, and during in-person visits, the participant is also administered a series
of neuropsychological tests by a trained research assistant. Some of the UDS forms are
completed by the study doctor but other UDS forms are completed by the research
assistant. During the initial study visit, the following data are collected: participant sex,
age (derived from month & year of birth); race; education; living situation; marital status,
health history and current medications. If an informant is present, he or she is asked about
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his/her relationship to the participant. If the informant does not live with the participant,
the frequency of the informant's visits/telephone calls to the participant is assessed. This
data is updated at each visit as necessary/appropriate.
Participants receive a brief physical exam at each study visit, are rated on the
Unified Parkinson’s Disease Rating Scale - Motor Exam, and are assigned a value on the
Hachinski Ischemic Score scale, a measure of vascular disease risk. In addition, the
following information is collected at each visit: participant score on the Clinical
Dementia Rating Scale (CDR); score on the Geriatric Depression Scale (GDS),
informant-reported score on the Neuropsychiatric Inventory Questionnaire (NPI-Q); and
score on the Functional Activities Questionnaire (FAQ). In addition, the following
cognitive tests are administered as part of the UDS: Mini Mental State Exam (MMSE);
Logical Memory I & II, Story A from the Wechsler Memory Scales, Revised Edition
(WMS-R, 1987); Digit Span Forward and Backward; Trail-Making Test A and B; DigitSymbol Coding from the Wechsler Adult Intelligence Scale, Revised edition (WAIS-R);
Category Fluency (Animals); and 30 odd-numbered items from the Boston Naming Test
(BNT). Based on the clinical interview, the study doctor assigns a diagnosis to each
participant at each visit. Diagnoses related to Alzheimer’s disease are made according to
criteria established by the National Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association
(NINCDS-ADRDA; McKhann et al., 1984). Diagnoses of vascular dementia are arrived
at according to criteria established by the National Institute of Neurological Disorders
and Stroke and the Association Internationale pour la Recherché et l'Enseignement en
Neurosciences (NINDS-AIREN; Roman et al., 1993).
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Analyses
Construction of Hierarchical Linear Models
Trajectories of longitudinal change were estimated using Hierarchical Linear
Modeling (HLM; Bryk & Raudenbush, 1987), a multi-level modeling technique that
predicts change over time within individuals as well as the variability in individual
trajectories over time. Longitudinal analysis in HLM is conceptualized as a two-level
model, wherein each participant’s development is modeled as an individual growth
trajectory plus random error at level 1 (within person change over time) and level 2
represents a between–person model that represents inter-individual differences in change.
Dependence in IADLs over time, as measured by mean FAQ item score, was the primary
outcome variable. Memory, executive function, depression, apathy, and medical burden
were treated as time-varying covariates and entered at level 1. Baseline diagnosis of
normal cognitive aging, MCI, Alzheimer’s disease or vascular dementia was considered a
time-invariant covariate at level 2. Because they are known to be associated with
functional impairment, age (Benke et al., 2013; Millán- Calenti, 2010), gender (Benke et
al., 2013; Maddox & Clark, 1992; Millán- Calenti, 2010), and level of education
(Maddox & Clark, 1992), were included as time-invariant controls and also entered at
level 2.
Model building began with an unconditional growth model to determine if there
was significant change in functional disability in IADLs over time, whether change in
IADLs was linear or curvilinear, and whether there was significant variability in that
change across individuals. This model served as a baseline model against which
subsequent models were compared. Level 1 of the model represents an individual’s (j’s)
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repeated measures of mean FAQ item score (y) across study visits (VISITNUM; from 1
to i). The intercept β0j represents person j’s expected value of y at study entry or baseline,
and slope β1j represents the expected linear rate of change in person j’s mean FAQ item
score as a function of time. Level 2 of the model estimates the average growth trajectory
across individuals, and indicates whether there is individual variation in trajectory
intercepts (β0j) and slopes (β1j) where γ represents the average intercept (γ00 ) and slope
(γ10) and u represents the individual j’s deviations from the average intercept (u0j ) and
average slope (u1).
Unconditional Model
Level 1
FAQij = β0j + β1j*(VISITNUMij) + rij
Level 2
β0j = γ00 + u0j
β1j = γ10 + u1j
Model Conditioned on Cognitive, Neuropsychiatric, and Medical Predictors
Next, five models were built, one each to include five other level 1 predictors that
were expected to themselves change across time and explain variation in mean FAQ item
scores over time. These predictors (i.e., episodic memory, executive function, depression,
apathy, and medical burden) were treated as time-varying covariates. Each predictor was
grand-mean centered and entered individually into the unconditional level 1 model to
determine its relationship with mean FAQ item score over time. After these five separate
models were run, one for each time-varying covariate, variables that showed a significant
relationship with mean FAQ item score over time were included together at level one in a
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final, conditional level 1 model. The conditional level 1 model allowed for random
effects to capture between-person variability in mean FAQ item score and apathy and
depressive symptom scores. It did not allow for random effects in memory and executive
function scores because univariate testing did not provide evidence for significant
variability across groups in the longitudinal relationships between these variables and
mean FAQ item score. This conditional level 1 model also served as the basis for
checking the HLM assumptions of homoscedasticity, linearity, independence, and
normality.
Model Conditioned on Baseline Diagnostic Status
A third model was built to determine the average level of functional disability by
initial diagnostic status (normal cognitive aging, MCI, Alzheimer’s disease, and vascular
dementia; diagnosis was treated as a time-invariant predictor at level 2), as well as the
average annual rate of change in mean FAQ item score for each group. Models allowed
for random effects to capture between-person variability in baseline and longitudinal
mean FAQ item scores. Persons with MCI, Alzheimer’s disease, and vascular dementia
were compared to the reference group of persons with normal cognitive aging.
Hypothesis tests were then performed to separately compare persons with MCI,
Alzheimer’s disease, and vascular dementia to each other, e.g., MCI to vascular
dementia, vascular dementia to Alzheimer’s disease, etc. Additional time-invariant
predictors including age, gender, and level of education were entered at level 2, one at a
time into this model to determine whether they should be included as control variables; a
variable that did not explain significant variability in mean FAQ item score was omitted
from the final model.

29

CHAPTER IV
RESULTS
Descriptive Statistics
Descriptive analyses revealed significant differences in diagnostic groups on
baseline measures (Table 2). Persons with normal cognitive aging took fewer prescription
medications than persons with MCI. Performance on Part B of the Trail-Making test was
significantly faster in persons with normal cognitive aging compared to those with MCI,
indicating that they were less taxed by this complex task. Persons with Alzheimer’s
disease performed significantly slower on Part B of the Trail-Making test than all other
groups. Persons with normal cognitive aging performed significantly better on the
memory test than persons with MCI, who themselves performed better than persons with
Alzheimer’s disease. Persons with vascular dementia also performed better on the
memory test than persons with Alzheimer’s disease.
Similar patterns were seen in baseline measures of neuropsychiatric symptoms.
Persons with normal cognitive aging evidenced significantly fewer depressive symptoms
than persons with MCI on the NPI-Q and the GDS. They also exhibited significantly less
apathy than persons with MCI, who as a group exhibited significantly less apathy at
baseline than persons with Alzheimer’s disease. Both informant and self-reported
neuropsychiatric symptoms were minimal across all diagnostic groups.
Most of the study variables at the baseline visit were significantly inter-correlated
(Table 3). Higher mean FAQ item scores were associated with poorer performance on
cognitive tests and higher ratings for depressive symptoms and apathy. Contrary to
prediction, number of prescription medications, an indicator of medical burden, only
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shared significant correlations with scores with depressive symptoms (both GDS and
NPI-Q) and executive functions, not with daily functioning. A small but significant
correlation was found between mean baseline FAQ item score and age (r = 0.22, p =
0.01).
Table 3
Correlation Matrix for Model Variables
1
1. FAQ
2. Trail Making Test B
3. WMS-R Logical Memory II
4. NPI-Q Depression
5. NPI-Q Depression
6. Number Medications
7. GDS

—

2
.57**
—

3

4

5

6

7

−.63**
−.44**
—

−.63**
.11**
−.14**
—

.52**
.25**
−.37**
.34**
—

.11*
.10*
−.02
.09**
.14**
—

.09
.29**
−.06
.21*
.06
.15
—

**p < .01. *p < .05.

Results of Hierarchical Linear Models
Longitudinal Change in Functional Disability
Results of the unconditional model, which included all diagnostic groups and no
predictors other than time, yielded a significant linear effect of time, indicating that on
average, participants’ mean FAQ item scores increased by 0.06 from one year to the next,
p < 0.001 (Table 4). That is, overall functional abilities significantly declined over time.
This model also revealed significant individual variability in the linear rate of change in
functional disability, χ2(422) = 978.49, p < 0.001, which suggests that some participants
declined faster than others. Indeed, some persons may have experienced no change in
their level of functional dependence and some may have become less dependent over
time (see Figure 1 for an illustration of the mean trajectories of change for each
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diagnostic group). This individual variability provides support for further examination of
predictors of variation in trajectories of functional disability.
Table 4
Model of Change in Functional Disability (Unconditional model)
Fixed effect

Coefficient

SE

t

Approx.
df

p

Mean initial status
Mean growth rate

0.03
0.06

0.02
0.01

11.22
5.65

640
640

<.001
<.001

Random effect

SD

Variance
component

df

χ2

p

0.55
0.16
0.25

0.30
0.03
0.06

422
422

993.83
978.49

<.001
<.001

Initial status
Growth rate
Level-1, e

1.31

Normal aging
Mild Cognitive Impairment
Alzheimer's disease

Mean FAQ Item Score

Vascular dementia
1.00

0.69

0.37

0.06
1.00

1.75

2.50

3.25

4.00

Visit Number

Figure 1. Mean longitudinal trajectories in mean FAQ item score by baseline diagnosis.
Variation by Cognitive Function, Neuropsychiatric Symptoms, and Medical Burden
Episodic memory, executive function, and depressive and apathy symptom scales
from the NPI-Q significantly improved the fit of the unconditional model and
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significantly predicted functional disability over time1 (Table 5). Inclusion of the number
of prescription medications taken by participants did not improve the model fit and
therefore was not included in the final conditional level 1 model. Self-reported depression
symptomatology, as measured by the GDS, was not included for the same reasons. When
these four variables were included together in the final conditional level 1 model,
depressive symptoms (as measured by the NPI) no longer significantly predicted
functional disability over time.
Table 5
Conditional Model of Change in Functional Disability
Fixed effect

Coefficient

SE

t

Approx.
df

p

Mean initial status
Mean growth rate
Memory slope
Executive function slope
Apathy slope*

0.31
0.033
−0.04
<0.001
0.31

0.22
<0.01
<0.01
<0.001
0.04

13.72
3.70
−15.47
13.40
7.63

640
640
1518
1518
640

<.001
<.001
<.001
<.001
<.001

Random effect

SD

Variance
component

df

χ2

p

0.37
0.09
0.32
0.28

0.13
<0.01
0.10
0.08

11
11
11

28.37
49.16
32.94

<.010
<.001
<.001

Initial status
Growth rate
Apathy slope
Level-1

Note. This model did not allow for random effects for memory or executive function.

Results from the final conditional level 1 model indicate that, controlling for
executive function and apathy symptoms, there was a 0.04 increase in mean FAQ item
score for every one-unit decrease in memory test performance. This suggests that
episodic memory performance is inversely related to functional disability; for the average

1

When the ratio of performance times on Trails A divided by Trails B was used
to represent executive function, the ratio did not significantly predict functional
disability.
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participant, worse memory performance predicts greater functional disability. There was
a significant positive relationship between executive function and functional disability,
such that mean FAQ item score increased by less than 0.001 for every one second
increase in completion time on part B of the Trail-Making test, controlling for memory
test scores and apathy symptoms. There also was a significant positive relationship
between apathy symptoms and functional disability; controlling for memory and
executive function, mean FAQ item score increased by 0.31 for every one unit increase
on the apathy scale of the NPI-Q. Thus, greater apathy and executive dysfunction were
associated with greater functional impairment.
Univariate models indicated that there was no significant individual variation in
the slopes of the associations between longitudinal episodic memory and executive
function performance and functional disability, indicating that the association between
these variables and functional disability is similar for all participants. Estimation of
variance components from the final conditional level 1 model reveals significant
variability in the slope of the relationship between longitudinal apathy symptoms and
functional disability. Therefore, controlling for memory and executive function, the
relationship between apathy symptoms and everyday functioning is different across
participants.
Examination of Baseline Age, Gender, and Level of Education
Participant age at study entry, gender, and level of education were added to the
model at level 2 to see whether they were associated with participants’ baseline and
longitudinal levels of functional disability. Gender was entered as an un-centered variable
and age and education were grand mean centered. Education did not significantly predict
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disability or improve the model fit and was excluded from the model. Baseline age and
gender emerged as significant predictors of disability, improved the model fit, and were
retained in the final model. However, in the conditional model that included age, gender,
and baseline diagnostic groups, gender no longer significantly predicted mean FAQ item
score at baseline; t (635) = 1.28, p = 0.20. Gender also no longer predicted longitudinal
rate of change in functional disability; t (635) = -0.54, p = 0.59. Age continued to predict
both mean FAQ item score at baseline [t (635) = 2.73, p < 0.01] and longitudinal
trajectories of functional decline [t (635) = -2.39, p = 0.02].
Baseline Levels of Functional Disability by Diagnostic Status
Baseline mean FAQ item score for the entire sample ranged from 0-3, with a
mean of 0.40 (SD = 0.73). Mean FAQ item score at baseline was significantly different
between diagnostic groups: F (3,639) = 104.502, p < 0.0001 (Table 2).
Functional disability at the baseline study visit was estimated for each diagnostic
group using the intercept for each group from the level 2 model (Table 6). The values for
persons with MCI, Alzheimer’s disease and vascular dementia represent the difference in
their baseline scores from the intercept for persons with normal cognitive aging, who
were selected as the reference group. Participant gender and age at baseline were
controlled. After controlling for gender and age, mean baseline FAQ item score for a
person with normal cognitive aging was 0.04, suggesting no appreciable functional
disability in this group at baseline (Table 6). As expected, persons with MCI exhibited a
baseline level of functional disability significantly greater than persons with normal
aging. Mean FAQ item scores were significantly higher at baseline for persons with
Alzheimer’s disease and vascular dementia than for normal controls.
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Table 6
Baseline Levels of and Rates of Change in Functional Disability by Baseline Diagnosis
Fixed effect

Coefficient

SE

t

Approx.
df

p

Baseline levels normal aging
Mild cognitive impairment
Alzheimer’s disease
Vascular dementia

0.04
0.13
0.68
0.42

0.04
0.06
0.06
0.12

1.01
2.09
11.22
3.34

635
635
635
635

.31
.04
<.001
<.001

Rates of change
Normal aging
Mild cognitive impairment
Alzheimer’s disease
Vascular dementia

<0.001
0.10
0.14
0.09

0.02
0.03
0.03
0.06

0.18
3.68
5.36
1.41

635
635
635
635

.86
<.001
<.001
.16

Note. All means are adjusted for age.

Participants with baseline diagnoses of MCI, AD, and vascular dementia also
were compared to each other through hypothesis testing in HLM. Mean baseline FAQ
item score for persons with MCI was significantly different from that for persons with
vascular dementia; χ2(1) = 4.65, p = 0.03. Baseline diagnosis of AD also was associated
with a significantly higher mean FAQ item score than for MCI, χ2 (1) = 61.86, p < 0.001.
A baseline diagnosis of AD also was associated with a significantly higher mean baseline
FAQ item score than a diagnosis of vascular dementia; χ2(1) = 4.26, p = 0.04. Residuals
for the level 1 and level 2 data files were checked and indicated that the data do not
violate the assumptions of linearity, homoscedasticity, independence and normality (see
Figures 2 and 3).
Longitudinal Trajectories of Functional Disability by Baseline Diagnostic Status
The ability to perform IADLs did not change significantly over the course of the
study in persons with baseline status of normal cognitive aging, controlling for baseline
age and gender (Table 6). Longitudinal trajectories of functional disability did not differ
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Figure 2. Level 1 residual plot.

Figure 3. Level 2 residual plot.
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significantly between persons with normal aging and persons diagnosed with vascular
dementia. Trajectories of functional decline also did not significantly differ in persons
with vascular dementia and MCI; χ2 (1) = 0.07, p >0.50. Compared to persons with
baseline status of normal cognitive aging, persons with baseline diagnoses of MCI and
Alzheimer’s disease experienced significantly greater impairment in function over time.
FAQ score increased by 0.10 annually for persons with MCI and 0.14 for persons with
Alzheimer’s disease, controlling for baseline age and gender. Change in functional
disability over time was not significantly greater in persons with Alzheimer’s disease
compared to persons with MCI; χ2 (1) = 1.63, p = 0.20. Trajectories of functional change
also were not significantly steeper in persons with Alzheimer’s disease compared to those
with vascular dementia; χ2 (1) = 0.84, p > 0.50.
Summary of Results
In summary, episodic memory, executive function, and apathy symptoms
independently predicted longitudinal decline in complex activities of daily living,
consistent with a priori hypotheses. Contrary to expectations, depressive symptoms and
medical burden did not predict longitudinal disability. Persons with a baseline diagnosis
of MCI exhibited a baseline level of functional disability that was intermediate to persons
with baseline classifications of normal aging and dementia, as expected. Also expected
were the significantly steeper trajectories of longitudinal functional decline in MCI and
Alzheimer’s disease compared to those seen in persons with normal aging at baseline.
The lack of significant difference in longitudinal rates of functional change in MCI and
Alzheimer’s disease was an unexpected finding. In the current study, persons with
Alzheimer’s disease exhibited significantly greater baseline functional disability than
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persons with vascular dementia, a finding that ran counter to expectations. Longitudinal
trajectories of disability in vascular dementia also were significantly flatter than in
Alzheimer’s disease. While a slower rate of decline in vascular dementia compared to
Alzheimer’s disease was expected, it was not expected that longitudinal decline of
functional abilities in persons with vascular dementia would not differ significantly from
persons with baseline classification of normal aging.
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CHAPTER V
DISCUSSION
This is the first study to simultaneously model the longitudinal relationships
between cognitive, neuropsychiatric, and medical predictors and functional disability.
This study also adds to the literature by separately comparing longitudinal rates of
functional decline in normal aging, MCI, and the two most common types of dementia,
Alzheimer’s disease and vascular dementia. Results from this study suggest that memory
and executive function independently predict change in complex activities of daily living
over time. Results also suggest that symptoms of apathy but not depression predict
longitudinal functional decline. Further, this study reveals that complex activities of daily
living decline faster in MCI and Alzheimer’s disease than in normal aging and vascular
dementia, and that these groups exhibit comparable rates of decline. A surprising finding
was the lack of significant longitudinal functional decline in vascular dementia.
Baseline Levels of Functional Disability by Diagnostic Group
Comparisons of baseline and longitudinal levels of functional disability between
persons with normal cognitive aging and those diagnosed with MCI, Alzheimer’s disease,
and vascular dementia partially support prior research. Normal cognitive aging was
associated with a minimal level of dependence at baseline and no significant change over
the course of the study, as expected. Persons with MCI demonstrated a level of baseline
disability that was greater than persons with normal aging and less than dementia,
consistent with previous findings and conforming to diagnostic conventions (Albert et al.,
2002; Aretouli & Brandt, 2010; Brown, Devanand, Liu, & Caccappolo, 2011; Farias et
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al., 2006; Pereira, Yassuda, Oliviera, & Forlenza, 2008; Wadley, Okonkwo, Crowe, &
Ross-Meadows, 2008).
Contrary to expectations, dementia groups did not exhibit comparable levels of
functional disability at baseline. Diagnosis of Alzheimer’s disease was associated with
the greatest level of dependence at baseline. The finding that vascular dementia was
associated with less functional dependence than Alzheimer’s disease is surprising, given
prior research documenting comparable levels of dependence in these groups (Boyle &
Cahn-Weiner, 2004; Gure et al., 2010). In this study, persons with vascular dementia
performed better on tests of memory and executive function than persons with
Alzheimer’s disease, indicating less impairment on key predictors of everyday
functioning. Memory and executive function in persons with vascular dementia were
more similar to persons with MCI in this study, and perhaps commensurately, so was
their performance on complex ADLs. In addition to their stronger cognitive testing
performance, methodological reasons may underlie the significantly lower level of
baseline functional disability in vascular dementia compared to Alzheimer’s disease. It is
possible that the small size of the vascular dementia sample did not allow for optimal
estimation of disability levels in this group, particularly considering the variability seen
in their FAQ scores and the heterogeneous nature of the diagnosis itself.
Longitudinal Trajectories of Functional Disability by Diagnostic Group
Longitudinal trajectories of change in functional disability were different between
groups. As expected, functional disability in persons with MCI progressed at a faster rate
than in persons with baseline classification of normal aging. Surprisingly, longitudinal
rates of change in functional disability were not significantly different in MCI and
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Alzheimer’s disease. In this study, the average score on an item of the FAQ for persons
with MCI increased by one tenth of one point annually, controlling for age. This
measurement represents the annual rate of change in any surveyed IADL for the average
person with MCI.
The comparable rate of functional decline in MCI and Alzheimer’s disease
contradicts results from one prior longitudinal study that measured intermediate rates of
functional decline in persons with MCI compared to persons with normal aging and
dementia (Tomaszewski Farias et al., 2009). There are several possible explanations for
this discrepancy. The current sample is comprised of persons from both clinic and
community sources compared to Tomaszewski Farias’s (2009) clinic-based sample and
indeed participants in this study were less functionally impaired at baseline than
participants in the other. Further, it is arguable that IADL items from the Blessed Roth
Dementia Rating Scale, the measure of functional disability used by Tomaszewski Farias
(2009), are less complex than IADLs included in the FAQ and therefore less sensitive to
annual change in less impaired persons, such as those with MCI. For example, IADL
items on the Blessed Roth include “tendency to dwell in past” and “find way about
indoors” and “interpret surroundings” whereas IADLs included on the FAQ include
“playing a game of skill” and “writing checks, paying bills, or balancing a checkbook.”
Viewed in this way, it is understandable how rates of functional change measured by the
FAQ in persons with MCI in the current study might be more similar to persons with
dementia than rates of change measured by the Blessed Roth.
Alternatively, it is possible that longitudinal rates of functional decline did not
significantly differ in persons with baseline diagnoses of MCI and Alzheimer’s disease
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because the majority of persons with Alzheimer’s disease in this study were in the mild
stages of disease. While baseline FAQ scores were significantly different in MCI versus
Alzheimer’s disease, baseline CDR scores were not significantly different in these
diagnostic groups. Mean baseline CDR scores for the Alzheimer’s disease group
represents a very mild stage of disease that may not be qualitatively different from MCI.
Another surprising finding was the lack of significant longitudinal functional
decline in vascular dementia compared to persons with normal aging. As stated
previously, the small size of the vascular dementia sample may have limited statistical
power to detect group differences. It also is possible that the time course of the study was
insufficient to detect functional decline in vascular dementia. Past research indicates that
functional decline in vascular dementia progresses at a slower rate than in Alzheimer’s
disease (Boyle & Cahn-Weiner, 2004; Gill et al., 2013). In addition, vascular dementia
caused by large infarcts, as opposed to cumulative small vessel disease, may progress in a
step-wise function and as such, significant changes in everyday function may not be
visible over the short-term (Boyle & Cahn-Weiner, 2004); unfortunately, more data about
subtypes of vascular dementia for participants in this study were not available.
Longitudinal Predictors of Functional Disability
Examination of the longitudinal relationships between cognitive, neuropsychiatric
and medical variables and everyday functioning revealed that cognitive performance and
apathy symptoms, and not depression or medical comorbidities, predict functional decline
over time. Performance on tests of memory and executive function, as well as informantreported apathy symptoms, predicted functional disability in a combined longitudinal
model, indicating that they confer independent effects on daily functioning.
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Memory
Declines in episodic memory performance predicted declines in performance of
complex activities of daily living. On the one hand, this finding is not surprising given
prior evidence of episodic memory’s cross-sectional associations with everyday
functioning (e.g., Burdick et al., 2002; Farias et al., 2004, Richardson, Nadler, & Malloy,
1995). The current results also align with those of Tomaszewski Farias et al. (2009),
showing a significant relationship between changes in episodic memory and changes in
IADL performance over time. The current finding that longitudinal episodic memory
performance independently predicts longitudinal functional decline is discrepant from
some prior research indicating that changes in episodic memory either are not
significantly related to functional change (Royall et al., 2005) or that the relationship
between memory and everyday functioning is moderated by executive functioning (CahnWeiner et al., 2007; Royall et al., 2005; Royall et al., 2007). Differences in the way
episodic memory was measured may explain these discrepancies. Episodic memory in the
current study was represented by participant scores on a delayed free recall trial of a
verbal learning test. Royall et al. (2005) used learning curve on a verbal list learning test
to represent episodic memory, which represents encoding but not necessarily the
storage/retrieval aspect of memory that is captured by delayed recall trials. Both CahnWeiner and colleagues (2007) and Tomaszewski- Farias et al. (2009) used composite
measures of memory performance in their studies; in the former, the composite
comprised scores from encoding and short delay recall trials of a list learning task, and
the latter used scores from encoding and long delay recall trials. Thus, significant
independent longitudinal relationships between episodic memory and IADL performance
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may be more likely when using delayed recall rather than encoding or immediate recall
scores: Scores on delayed recall trials may be a better indicator of memory decline than
encoding or free recall performance.
It is easy to understand how memory abilities predict IADL performance because
many of the items on the FAQ require memory skills both prospectively (e.g.,
remembering items that need to be purchased on a shopping trip, remembering
appointments, remembering the need to pay bills and what needs to be accomplished
when assembling paperwork) as well as during the execution of tasks (e.g. keeping track
of current events or the content of TV shows, movies, books and magazines).
Interestingly, the longitudinal relationship between memory and functional disability did
not vary across study participants. This suggests that declines in memory predict
increased functional disability regardless of diagnosis or the magnitude of pre-existing
cognitive or functional impairment: A change in memory does not precipitate steeper
functional declines in dementia than it does in MCI or in normal aging.
Executive Function
This study also provided evidence for a longitudinal association between
executive functions and functional abilities, consistent with results from prior research
showing that executive function longitudinally predicts everyday functioning (Royall et
al., 2005; Tomaszewski Farias et al., 2009). This finding was expected given that several
IADLs included in the FAQ seem to require the ability to plan, sequence, and organize
one’s behavior (preparing a balanced meal, playing a game of skill, traveling, etc.).
Results from this study further provide additional evidence for the power of Part B of the
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Trail-Making Test specifically in predicting IADL performance in older adults with and
without dementia (Bell -McGinty et al., 2002; Burdick et al., 2005; Yeh et al., 2011).
As with memory, the relationship between executive function and everyday
functioning did not vary significantly between participants, indicating that declines in
executive function are associated with similar declines in functional abilities regardless of
diagnosis. It is possible that the same physiological processes that underline declines in
executive abilities also drive functional disability. Decreased volume in the orbitofrontal
cortex, the site of reward and decision-making behaviors, is associated with functional
impairments in older adults, independent of total brain volume (Taylor et al., 2003).
Recent research also indicates that hypoperfusion in the right precuneus, part of the
associative cortex, is associated with declines in performance on both a set-shifting task
and the FAQ (Chao et al., 2010).
Neuropsychiatric Symptoms
Apathy and not depressive symptoms predicted longitudinal declines in daily
functioning. Longitudinal associations between depressive symptoms and functional
decline were expected, given prior research documenting relationships between
depression and poorer daily functioning in persons with cognitive impairment (DeRonchi
et al., 2005; Fitz & Teri, 1994). One possible reason that depressive symptoms were not
associated with function in this study is the paucity of depressive symptoms reported for
participants; informant reports of depressive symptoms were extremely low for all study
groups, and participants themselves endorsed minimal depressive symptoms. Limited
variability in depression scores may have made it difficult to discern relationships with
functional disability. Further, such a low frequency and severity of neuropsychiatric
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symptoms is unusual for persons with cognitive impairment (Edwards et al., 2009;
Lyketsos et al., 2002; Steinberg et al., 2008) and also may explain differences from other
studies.
This study revealed a significant longitudinal relationship between greater apathy
and decline in complex activities of daily living despite minimal informant-reported
apathy symptoms, providing support for the association between this syndrome and
functional impairment. The current results align with prior research documenting stronger
associations between apathy and functional disability compared to depression in persons
with dementia (Clarke et al., 2008; Zawacki et al., 2002) and in amnestic MCI (Zahodne
& Tremont, 2013).
Key symptoms of apathy include decreased motivation, initiation, and persistence
(Ishii et al., 2009), behavioral components that are necessary for task performance.
Apathy has been related in Alzheimer’s disease patients to impairments in planning,
initiating and executing IADLs, in contrast to depression, which relates only with
impaired initiation and planning (Lam et al., 2006). Therefore, it may be that reduced
desire/drive to persist in and complete tasks accounts for apathy’s particularly negative
impact on daily functioning.
Medical Burden
Results from this study did not support the hypothesis that greater medical burden
would predict greater functional disability, which suggests that physical health does not
factor into the performance of complex activities of daily living. These results contradict
prior findings of significant relationships between poor health and functional disability in
nursing home and assisted living residents (Burdick et al., 2005; Lyketsos et al., 1999)
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but align with results from a study of IADL performance in an outpatient Alzheimer’s
disease sample (Tekin et al., 2001). Methodological differences may underlie these
contrasting results. First, it is possible that there is greater variability in both physical
health and functional dependence in persons living in professional facilities than in
outpatients, which may increase the likelihood of finding a significant relationship
between medical burden and daily functioning in facility samples. Second, there are
many ways to operationalize medical burden. This study utilized total medication count
to represent burden, which has compared favorably to other, more complex assessments
of medical comorbidity (Perkins et al., 2004). However, medication counts may be less
sensitive than the health surveys used in other studies that include specific medical
conditions, such as arthritis, back pain, or a physical disability, that may not require
medication but that nevertheless impact daily functioning. Third, ADL assessments differ
across studies. Medical burden may have a stronger association with certain ADLs (i.e.,
traveling out of the neighborhood, grooming and personal hygiene) and less so with
others (i.e., keeping track of current events), depending on the nature of the task.
Functional disability questionnaires that include both BADLs and IADLs of the type used
by Burdick et al. (2005), or that include more IADLs with a physical component, may
share stronger relationships with medical burden than those that do not.
Limitations
The current study has several limitations. First, the study sample overall was highfunctioning. Mean total FAQ score for all groups at baseline was 2.56 out of a possible
30. There was a floor effect in the FAQ for normal controls and persons with MCI. While
the dementia groups included persons with a range of cognitive impairment, persons with
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Alzheimer’s disease and vascular dementia were on average at very mild stages of
disease based on analysis of baseline CDR scores. As stated previously, minimal levels of
depressive and apathy symptoms were endorsed by informants for all groups. In addition
to these generally high levels of emotional and behavioral functioning, the majority of
study participants were Caucasian, married, and living at home with a spouse or partner.
They had on average a college education, and many participants had Master’s,
professional, and doctoral degrees, which could indicate solid cognitive reserve that
might moderate the outward manifestation of brain pathology (Stern, 2012). For the
above reasons, results from this study may not generalize to the greater population of
persons with MCI, Alzheimer’s disease, and vascular dementia. Finally, functional
performance was measured using a scale that assessed IADLs only and did not include
BADLs. Therefore, estimates of longitudinal change in daily functioning based on
memory and executive function performance, and rates of change by baseline diagnosis,
apply only to higher-level activities and not to basic activities of daily living such as
eating, bathing, and dressing.
Conclusions
Results from this study, while based in an overall high-functioning sample,
provide evidence that longitudinal memory and executive function performance, as well
as apathy symptoms independently predict daily functioning. Thus, in terms of cognitive
abilities, clinicians and caregivers should expect that changes in both memory and
executive function will correspond with subtle changes in the performance of everyday
activities. Interestingly, the nature of the relationship between memory and executive
function declines and functional disability appears to be similar for persons with normal
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cognitive aging, MCI, and dementia. Therefore, providers should not expect more rapid
functional decline given a change in cognitive performance in dementia than in MCI.
With regard to neuropsychiatric symptoms, results indicate that apathy is a potentially
modifiable predictor of longitudinal functional decline. Future research should address
whether aggressive psychological and pharmacological treatment can palliate its adverse
effects on complex daily living activities. Clinicians and caregivers also should expect
significant and progressive functional decline in persons with MCI and Alzheimer’s
disease. However, this study suggests that disablement is gradual even in persons with
Alzheimer’s disease, which may offer some hope to patients and their caregivers.
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